International Journal of Colorectal Disease

, Volume 24, Issue 3, pp 283–288 | Cite as

Lymph node examination as a predictor of long-term outcome in Dukes B colon cancer

  • Ryash Vather
  • Tarik Sammour
  • Kamran Zargar-Shoshtari
  • Patricia Metcalf
  • Andrew Connolly
  • Andrew HillEmail author
Original Article



Mortality from cancer recurrence in Dukes B patients is approximately 25–30%. Outcome in Dukes B patients improves in direct relation to the number of lymph nodes examined. Examining fewer lymph nodes risks understaging and also such patients are less likely to receive chemotherapy. The aim of this study was to assess the impact of the number of lymph nodes examined on recurrence and mortality in Dukes B colon cancers.

Materials and methods

A retrospective database was constructed of 328 consecutive patients who underwent resection for Dukes B colorectal cancer between January 1993 and December 2001 at Middlemore Hospital. Patients with incomplete data, previous colorectal cancer, or perioperative deaths were excluded as were cases of rectal cancer. Data for the remaining 216 patients was subjected to multivariate and logistic regression analysis with ‘patient death’ or ‘cancer recurrence’ (CRec5) within 5 years as endpoints. A graph was constructed depicting CRec5 as broken down by lymph node strata. Receiver operator characteristic (ROC) curves were constructed for mortality and CRec5.


The mean number of lymph nodes examined was 16.0 (median 14; range 2–48). The mean number of lymph nodes examined in those who died within 5 years was 12.8 vs. 17.5 in those who remained alive (p = 0.0027). The mean number of lymph nodes examined in those with evidence of recurrence within 5 years was 11.8 vs. 17.1 in those without recurrence (p = 0.0007). Analysis at various lymph node strata showed a sharp and statistically significant drop in the recurrence rate after the 16the node mark. The ROC curve for CRec5 showed that examination of 12 lymph nodes provided maximum sensitivity (0.60) and specificity (0.64).


Examination of more than 16 lymph nodes is associated with a significant reduction in cancer recurrence. This supports the current clinical practice of harvesting and analysing as many nodes as possible during surgical resection and pathological analysis.


Colon cancer Dukes B Lymph node Mortality Recurrence 


  1. 1.
    Schottenfeld D, Winawer SJ (1996) Cancers of the large intestine. In: Schottenfeld D, Fraumeni JF (eds) Cancer epidemiology and prevention, Second edition. Oxford University Press, New YorkGoogle Scholar
  2. 2.
    Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, Hammond ME, Henson DE, Hutter RV, Nagle RB, Nielsen ML, Sargent DJ, Taylor CR, Welton M, Willett C (2000) Prognostic factors in colorectal cancer: College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124:979–994PubMedGoogle Scholar
  3. 3.
    Figueredo A, Fine S, Maroun J, Walker-Dilks C, Wong S (1997) Adjuvant therapy for stage III colon cancer after complete resection. Cancer Prev Control 1(4):304–319PubMedGoogle Scholar
  4. 4.
    Wang Y, Jatkoe T, Zhang Y, Mutch MG, Talantov D, Jiang J, McLeod HL, Atkins D (2004) Gene expression profiles and molecular markers to predict recurrence of Dukes’ B colon cancer. J Clin Oncol 22:1564–1571PubMedCrossRefGoogle Scholar
  5. 5.
    Goldstein NS, Sanford W, Coffey M, Layfield LJ (1996) Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol 106:209–216PubMedGoogle Scholar
  6. 6.
    Hernanz F, Revuelta S, Redondo C, Madrazo C, Castillo J, Gomez-Fleitas M (1994) Colorectal adenocarcinoma: quality of the assessment of lymph node metastases. Dis Colon Rectum 37:373–377PubMedCrossRefGoogle Scholar
  7. 7.
    Swanson RS, Compton CC, Stewart AK, Bland KI (2003) The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 10:65–71PubMedCrossRefGoogle Scholar
  8. 8.
    Wong JH, Severino R, Honnebier MB, Tom P, Namiki TS (1999) Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol 17:2896–2900PubMedGoogle Scholar
  9. 9.
    Census of population and dwellings, Statistics New ZealandGoogle Scholar
  10. 10.
    SAS Institute Inc (2004) SAS/STAT User's Guide. Version 9.1. SAS Institute, Cary, NCGoogle Scholar
  11. 11.
    Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29–36PubMedGoogle Scholar
  12. 12.
    Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA (2007) Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 99(6):433–441PubMedCrossRefGoogle Scholar
  13. 13.
    Wong S, Ji H, Hollenbeck B, Morris A, Baser O (2007) Hospital lymph node examination rates and survival after resection for colon cancer. JAMA 298(18):2149–2154PubMedCrossRefGoogle Scholar
  14. 14.
    Fielding LP, Arsenault PA, Chapuis PH, Dent O, Gathright B, Hardcastle JD, Hermanek P, Jass JR, Newland RC (1991) Clinicopathological staging for colorectal cancer: an International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT). J Gastroenterol Hepatol 6:325–344PubMedCrossRefGoogle Scholar
  15. 15.
    National Quality Forum. Specifications of the national voluntary consensus standards for breast and colon cancer.
  16. 16.
    Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, Virnig BA (2005) Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst 97(3):219–225PubMedCrossRefGoogle Scholar
  17. 17.
    Wright FC, Law CH, Last L, Khalifa M, Arnaout A, Naseer Z, Klar N, Gallinger S, Smith AJ (2003) Lymph node retrieval and assessment in stage II colorectal cancer: a population-based study. Ann Surg Oncol 10:903–909PubMedCrossRefGoogle Scholar
  18. 18.
    Goldstein NS (2002) Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol 26:179–189PubMedCrossRefGoogle Scholar
  19. 19.
    Evans MD, Barton K, Rees A, Stamatakis JD, Karandikar SS (2008) The impact of surgeon and pathologist on lymph node retrieval in colorectal cancer and its impact on survival for patients with Dukes’ stage B disease. Colorectal Dis 10(2):157–164PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Ryash Vather
    • 1
  • Tarik Sammour
    • 1
  • Kamran Zargar-Shoshtari
    • 1
  • Patricia Metcalf
    • 2
  • Andrew Connolly
    • 1
  • Andrew Hill
    • 1
    Email author
  1. 1.Department of Surgery, South Auckland Clinical SchoolUniversity of AucklandOtahuhu, AucklandNew Zealand
  2. 2.Department of StatisticsUniversity of AucklandAucklandNew Zealand

Personalised recommendations